APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmacovigilance (PV) Outsourcing

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmacovigilance (PV) Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174025270320 December 2025192 pages

Choose your research edition.

Industry ResearchPharmacovigilance (PV) Outsourcing Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacovigilance (PV) Outsourcing Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pharmacovigilance (PV) Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacovigilance (PV) Outsourcing Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmacovigilance (PV) Outsourcing Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Pharmacovigilance (PV) Outsourcing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmacovigilance (PV) Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmacovigilance (PV) Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacovigilance (PV) Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmacovigilance (PV) Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmacovigilance (PV) Outsourcing include Accenture, C3i Solutions, Clintec, Covance, Deloitte Touche Tohmatsu Limited, ELC Group, Ergomed, iGATE Corporation and iMED Global Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmacovigilance (PV) Outsourcing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacovigilance (PV) Outsourcing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacovigilance (PV) Outsourcing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmacovigilance (PV) Outsourcing market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmacovigilance (PV) Outsourcing Segment by Company

Accenture

C3i Solutions

Clintec

Covance

Deloitte Touche Tohmatsu Limited

ELC Group

Ergomed

iGATE Corporation

iMED Global Corporation

IQVIA

MarksMan Healthcare

Medpace Holdings

Oracle Corporation

Parexel

PharmInvent

PrimeVigilance

Pure Drug Safety

Sciformix

SIRO Clinpharm

Symogen

Novartis

Pharmacovigilance (PV) Outsourcing Segment by Type

Contract Research Organizations (CROs)

Business Process Outsourcing (BPOs)

Pharmacovigilance (PV) Outsourcing Segment by Application

Premarketing Clinical Trial

Post-marketing Clinical Practice

Other

Pharmacovigilance (PV) Outsourcing Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacovigilance (PV) Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacovigilance (PV) Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacovigilance (PV) Outsourcing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmacovigilance (PV) Outsourcing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacovigilance (PV) Outsourcing industry.

Chapter 3: Detailed analysis of Pharmacovigilance (PV) Outsourcing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmacovigilance (PV) Outsourcingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Contract Research Organizations (CROs) Table 3. Key Players of Business Process Outsourcing (BPOs) Table 4. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Premarketing Clinical Trial Table 6. Key Players of Post-marketing Clinical Practice Table 7. Key Players of Other Table 8. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2021-2026) Table 11. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2027-2032) Table 13. Pharmacovigilance (PV) Outsourcing Industry Trends Table 14. Pharmacovigilance (PV) Outsourcing Industry Drivers Table 15. Pharmacovigilance (PV) Outsourcing Industry Opportunities and Challenges Table 16. Pharmacovigilance (PV) Outsourcing Industry Restraints Table 17. Global Pharmacovigilance (PV) Outsourcing Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Company (2021-2026) Table 19. Global Pharmacovigilance (PV) Outsourcing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pharmacovigilance (PV) Outsourcing Key Company Head Office and Area Served Table 21. Global Pharmacovigilance (PV) Outsourcing Company, Product Type & Application Table 22. Global Pharmacovigilance (PV) Outsourcing Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Pharmacovigilance (PV) Outsourcing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Pharmacovigilance (PV) Outsourcing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2021-2026) Table 29. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2027-2032) Table 30. Global Pharmacovigilance (PV) Outsourcing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2021-2026) Table 34. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2027-2032) Table 35. Accenture Company Information Table 36. Accenture Business Overview Table 37. Accenture Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Accenture Pharmacovigilance (PV) Outsourcing Product Portfolio Table 39. Accenture Recent Development Table 40. C3i Solutions Company Information Table 41. C3i Solutions Business Overview Table 42. C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. C3i Solutions Pharmacovigilance (PV) Outsourcing Product Portfolio Table 44. C3i Solutions Recent Development Table 45. Clintec Company Information Table 46. Clintec Business Overview Table 47. Clintec Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Clintec Pharmacovigilance (PV) Outsourcing Product Portfolio Table 49. Clintec Recent Development Table 50. Covance Company Information Table 51. Covance Business Overview Table 52. Covance Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Covance Pharmacovigilance (PV) Outsourcing Product Portfolio Table 54. Covance Recent Development Table 55. Deloitte Touche Tohmatsu Limited Company Information Table 56. Deloitte Touche Tohmatsu Limited Business Overview Table 57. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Portfolio Table 59. Deloitte Touche Tohmatsu Limited Recent Development Table 60. ELC Group Company Information Table 61. ELC Group Business Overview Table 62. ELC Group Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. ELC Group Pharmacovigilance (PV) Outsourcing Product Portfolio Table 64. ELC Group Recent Development Table 65. Ergomed Company Information Table 66. Ergomed Business Overview Table 67. Ergomed Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Ergomed Pharmacovigilance (PV) Outsourcing Product Portfolio Table 69. Ergomed Recent Development Table 70. iGATE Corporation Company Information Table 71. iGATE Corporation Business Overview Table 72. iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. iGATE Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio Table 74. iGATE Corporation Recent Development Table 75. iMED Global Corporation Company Information Table 76. iMED Global Corporation Business Overview Table 77. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio Table 79. iMED Global Corporation Recent Development Table 80. IQVIA Company Information Table 81. IQVIA Business Overview Table 82. IQVIA Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. IQVIA Pharmacovigilance (PV) Outsourcing Product Portfolio Table 84. IQVIA Recent Development Table 85. MarksMan Healthcare Company Information Table 86. MarksMan Healthcare Business Overview Table 87. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Portfolio Table 89. MarksMan Healthcare Recent Development Table 90. Medpace Holdings Company Information Table 91. Medpace Holdings Business Overview Table 92. Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Portfolio Table 94. Medpace Holdings Recent Development Table 95. Oracle Corporation Company Information Table 96. Oracle Corporation Business Overview Table 97. Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio Table 99. Oracle Corporation Recent Development Table 100. Parexel Company Information Table 101. Parexel Business Overview Table 102. Parexel Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Parexel Pharmacovigilance (PV) Outsourcing Product Portfolio Table 104. Parexel Recent Development Table 105. PharmInvent Company Information Table 106. PharmInvent Business Overview Table 107. PharmInvent Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. PharmInvent Pharmacovigilance (PV) Outsourcing Product Portfolio Table 109. PharmInvent Recent Development Table 110. PrimeVigilance Company Information Table 111. PrimeVigilance Business Overview Table 112. PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Portfolio Table 114. PrimeVigilance Recent Development Table 115. Pure Drug Safety Company Information Table 116. Pure Drug Safety Business Overview Table 117. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Portfolio Table 119. Pure Drug Safety Recent Development Table 120. Sciformix Company Information Table 121. Sciformix Business Overview Table 122. Sciformix Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Sciformix Pharmacovigilance (PV) Outsourcing Product Portfolio Table 124. Sciformix Recent Development Table 125. SIRO Clinpharm Company Information Table 126. SIRO Clinpharm Business Overview Table 127. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Portfolio Table 129. SIRO Clinpharm Recent Development Table 130. Symogen Company Information Table 131. Symogen Business Overview Table 132. Symogen Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Symogen Pharmacovigilance (PV) Outsourcing Product Portfolio Table 134. Symogen Recent Development Table 135. Novartis Company Information Table 136. Novartis Business Overview Table 137. Novartis Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. Novartis Pharmacovigilance (PV) Outsourcing Product Portfolio Table 139. Novartis Recent Development Table 140. North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 141. North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2027-2032) & (US$ Million) Table 142. North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 143. North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2027-2032) & (US$ Million) Table 144. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026) Table 146. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2027-2032) Table 147. Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 148. Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2027-2032) & (US$ Million) Table 149. Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 150. Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2027-2032) & (US$ Million) Table 151. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026) Table 153. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2027-2032) Table 154. China Pharmacovigilance (PV) Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 155. China Pharmacovigilance (PV) Outsourcing Market Size by Type (2027-2032) & (US$ Million) Table 156. China Pharmacovigilance (PV) Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 157. China Pharmacovigilance (PV) Outsourcing Market Size by Application (2027-2032) & (US$ Million) Table 158. Asia Pharmacovigilance (PV) Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 159. Asia Pharmacovigilance (PV) Outsourcing Market Size by Type (2027-2032) & (US$ Million) Table 160. Asia Pharmacovigilance (PV) Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 161. Asia Pharmacovigilance (PV) Outsourcing Market Size by Application (2027-2032) & (US$ Million) Table 162. Asia Pharmacovigilance (PV) Outsourcing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Asia Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026) Table 164. Asia Pharmacovigilance (PV) Outsourcing Market Size by Country (2027-2032) Table 165. South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 166. South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2027-2032) & (US$ Million) Table 167. South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 168. South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2027-2032) & (US$ Million) Table 169. South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026) Table 171. South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2027-2032) Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Pharmacovigilance (PV) Outsourcing Product Image Figure 2. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmacovigilance (PV) Outsourcing Market Share by Type: 2025 VS 2032 Figure 4. Contract Research Organizations (CROs) Image Figure 5. Business Process Outsourcing (BPOs) Image Figure 6. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Pharmacovigilance (PV) Outsourcing Market Share by Application: 2025 VS 2032 Figure 8. Premarketing Clinical Trial Image Figure 9. Post-marketing Clinical Practice Image Figure 10. Other Image Figure 11. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 13. Global Pharmacovigilance (PV) Outsourcing Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Pharmacovigilance (PV) Outsourcing Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Pharmacovigilance (PV) Outsourcing Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2021-2032) Figure 20. Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Application (2021-2032) Figure 22. North America Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 23. North America Pharmacovigilance (PV) Outsourcing Market Share by Type (2021-2032) Figure 24. North America Pharmacovigilance (PV) Outsourcing Market Share by Application (2021-2032) Figure 25. North America Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2032) Figure 26. United States Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 27. Canada Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 29. Europe Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 30. Europe Pharmacovigilance (PV) Outsourcing Market Share by Type (2021-2032) Figure 31. Europe Pharmacovigilance (PV) Outsourcing Market Share by Application (2021-2032) Figure 32. Europe Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2032) Figure 33. Germany Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 34. France Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 36. Italy Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 37. Russia Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 39. China Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 40. China Pharmacovigilance (PV) Outsourcing Market Share by Type (2021-2032) Figure 41. China Pharmacovigilance (PV) Outsourcing Market Share by Application (2021-2032) Figure 42. Asia Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 43. Asia Pharmacovigilance (PV) Outsourcing Market Share by Type (2021-2032) Figure 44. Asia Pharmacovigilance (PV) Outsourcing Market Share by Application (2021-2032) Figure 45. Asia Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2032) Figure 46. Japan Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 50. India Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 51. Australia Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2032) Figure 56. Brazil Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 61. UAE Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 63. Chile Pharmacovigilance (PV) Outsourcing Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Contract Research Organizations (CROs)
  • Business Process Outsourcing (BPOs)
Applications
  • Premarketing Clinical Trial
  • Post-marketing Clinical Practice
  • Other
Companies covered
  • Accenture
  • C3i Solutions
  • Clintec
  • Covance
  • Deloitte Touche Tohmatsu Limited
  • ELC Group
  • Ergomed
  • iGATE Corporation
  • iMED Global Corporation
  • IQVIA
  • MarksMan Healthcare
  • Medpace Holdings
  • Oracle Corporation
  • Parexel
  • PharmInvent
  • PrimeVigilance
  • Pure Drug Safety
  • Sciformix
  • SIRO Clinpharm
  • Symogen
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Contract Research Organizations (CROs)
  5. 1.2.3 Business Process Outsourcing (BPOs)
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Premarketing Clinical Trial
  9. 1.3.3 Post-marketing Clinical Practice
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Pharmacovigilance (PV) Outsourcing Growth Trends by Region
  13. 1.5.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Pharmacovigilance (PV) Outsourcing Market Size by Region (2021-2026)
  15. 1.5.3 Pharmacovigilance (PV) Outsourcing Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Pharmacovigilance (PV) Outsourcing Market Dynamics
  1. 2.1 Pharmacovigilance (PV) Outsourcing Industry Trends
  2. 2.2 Pharmacovigilance (PV) Outsourcing Industry Drivers
  3. 2.3 Pharmacovigilance (PV) Outsourcing Industry Opportunities and Challenges
  4. 2.4 Pharmacovigilance (PV) Outsourcing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmacovigilance (PV) Outsourcing Revenue by Company (2021-2026)
  2. 3.2 Global Pharmacovigilance (PV) Outsourcing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmacovigilance (PV) Outsourcing Key Company Head office and Area Served
  4. 3.4 Global Pharmacovigilance (PV) Outsourcing Company, Product Type & Application
  5. 3.5 Global Pharmacovigilance (PV) Outsourcing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmacovigilance (PV) Outsourcing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmacovigilance (PV) Outsourcing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmacovigilance (PV) Outsourcing Tier 1, Tier 2, and Tier 3
4 Pharmacovigilance (PV) Outsourcing Market by Type
  1. 4.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2021-2032)
  3. 4.3 Global Pharmacovigilance (PV) Outsourcing Market Size Share by Type (2021-2032)
5 Pharmacovigilance (PV) Outsourcing Market by Application
  1. 5.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2021-2032)
  3. 5.3 Global Pharmacovigilance (PV) Outsourcing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Accenture
  2. 6.1.1 Accenture Company Information
  3. 6.1.2 Accenture Business Overview
  4. 6.1.3 Accenture Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Accenture Pharmacovigilance (PV) Outsourcing Product Portfolio
  6. 6.1.5 Accenture Recent Developments
  7. 6.2 C3i Solutions
  8. 6.2.1 C3i Solutions Company Information
  9. 6.2.2 C3i Solutions Business Overview
  10. 6.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 C3i Solutions Pharmacovigilance (PV) Outsourcing Product Portfolio
  12. 6.2.5 C3i Solutions Recent Developments
  13. 6.3 Clintec
  14. 6.3.1 Clintec Company Information
  15. 6.3.2 Clintec Business Overview
  16. 6.3.3 Clintec Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Clintec Pharmacovigilance (PV) Outsourcing Product Portfolio
  18. 6.3.5 Clintec Recent Developments
  19. 6.4 Covance
  20. 6.4.1 Covance Company Information
  21. 6.4.2 Covance Business Overview
  22. 6.4.3 Covance Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Covance Pharmacovigilance (PV) Outsourcing Product Portfolio
  24. 6.4.5 Covance Recent Developments
  25. 6.5 Deloitte Touche Tohmatsu Limited
  26. 6.5.1 Deloitte Touche Tohmatsu Limited Company Information
  27. 6.5.2 Deloitte Touche Tohmatsu Limited Business Overview
  28. 6.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Portfolio
  30. 6.5.5 Deloitte Touche Tohmatsu Limited Recent Developments
  31. 6.6 ELC Group
  32. 6.6.1 ELC Group Company Information
  33. 6.6.2 ELC Group Business Overview
  34. 6.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 ELC Group Pharmacovigilance (PV) Outsourcing Product Portfolio
  36. 6.6.5 ELC Group Recent Developments
  37. 6.7 Ergomed
  38. 6.7.1 Ergomed Company Information
  39. 6.7.2 Ergomed Business Overview
  40. 6.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Ergomed Pharmacovigilance (PV) Outsourcing Product Portfolio
  42. 6.7.5 Ergomed Recent Developments
  43. 6.8 iGATE Corporation
  44. 6.8.1 iGATE Corporation Company Information
  45. 6.8.2 iGATE Corporation Business Overview
  46. 6.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 iGATE Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
  48. 6.8.5 iGATE Corporation Recent Developments
  49. 6.9 iMED Global Corporation
  50. 6.9.1 iMED Global Corporation Company Information
  51. 6.9.2 iMED Global Corporation Business Overview
  52. 6.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
  54. 6.9.5 iMED Global Corporation Recent Developments
  55. 6.10 IQVIA
  56. 6.10.1 IQVIA Company Information
  57. 6.10.2 IQVIA Business Overview
  58. 6.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 IQVIA Pharmacovigilance (PV) Outsourcing Product Portfolio
  60. 6.10.5 IQVIA Recent Developments
  61. 6.11 MarksMan Healthcare
  62. 6.11.1 MarksMan Healthcare Company Information
  63. 6.11.2 MarksMan Healthcare Business Overview
  64. 6.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Portfolio
  66. 6.11.5 MarksMan Healthcare Recent Developments
  67. 6.12 Medpace Holdings
  68. 6.12.1 Medpace Holdings Company Information
  69. 6.12.2 Medpace Holdings Business Overview
  70. 6.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Portfolio
  72. 6.12.5 Medpace Holdings Recent Developments
  73. 6.13 Oracle Corporation
  74. 6.13.1 Oracle Corporation Company Information
  75. 6.13.2 Oracle Corporation Business Overview
  76. 6.13.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
  78. 6.13.5 Oracle Corporation Recent Developments
  79. 6.14 Parexel
  80. 6.14.1 Parexel Company Information
  81. 6.14.2 Parexel Business Overview
  82. 6.14.3 Parexel Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Parexel Pharmacovigilance (PV) Outsourcing Product Portfolio
  84. 6.14.5 Parexel Recent Developments
  85. 6.15 PharmInvent
  86. 6.15.1 PharmInvent Company Information
  87. 6.15.2 PharmInvent Business Overview
  88. 6.15.3 PharmInvent Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 PharmInvent Pharmacovigilance (PV) Outsourcing Product Portfolio
  90. 6.15.5 PharmInvent Recent Developments
  91. 6.16 PrimeVigilance
  92. 6.16.1 PrimeVigilance Company Information
  93. 6.16.2 PrimeVigilance Business Overview
  94. 6.16.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Portfolio
  96. 6.16.5 PrimeVigilance Recent Developments
  97. 6.17 Pure Drug Safety
  98. 6.17.1 Pure Drug Safety Company Information
  99. 6.17.2 Pure Drug Safety Business Overview
  100. 6.17.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Portfolio
  102. 6.17.5 Pure Drug Safety Recent Developments
  103. 6.18 Sciformix
  104. 6.18.1 Sciformix Company Information
  105. 6.18.2 Sciformix Business Overview
  106. 6.18.3 Sciformix Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Sciformix Pharmacovigilance (PV) Outsourcing Product Portfolio
  108. 6.18.5 Sciformix Recent Developments
  109. 6.19 SIRO Clinpharm
  110. 6.19.1 SIRO Clinpharm Company Information
  111. 6.19.2 SIRO Clinpharm Business Overview
  112. 6.19.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Portfolio
  114. 6.19.5 SIRO Clinpharm Recent Developments
  115. 6.20 Symogen
  116. 6.20.1 Symogen Company Information
  117. 6.20.2 Symogen Business Overview
  118. 6.20.3 Symogen Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Symogen Pharmacovigilance (PV) Outsourcing Product Portfolio
  120. 6.20.5 Symogen Recent Developments
  121. 6.21 Novartis
  122. 6.21.1 Novartis Company Information
  123. 6.21.2 Novartis Business Overview
  124. 6.21.3 Novartis Pharmacovigilance (PV) Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Novartis Pharmacovigilance (PV) Outsourcing Product Portfolio
  126. 6.21.5 Novartis Recent Developments
7 North America
  1. 7.1 North America Pharmacovigilance (PV) Outsourcing Market Size (2021-2032)
  2. 7.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Type
  3. 7.2.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmacovigilance (PV) Outsourcing Market Share by Type (2021-2032)
  6. 7.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Application
  7. 7.3.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmacovigilance (PV) Outsourcing Market Share by Application (2021-2032)
  10. 7.4 North America Pharmacovigilance (PV) Outsourcing Market Size by Country
  11. 7.4.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmacovigilance (PV) Outsourcing Market Size (2021-2032)
  2. 8.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type
  3. 8.2.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmacovigilance (PV) Outsourcing Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application
  7. 8.3.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmacovigilance (PV) Outsourcing Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country
  11. 8.4.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmacovigilance (PV) Outsourcing Market Size (2021-2032)
  2. 9.2 China Pharmacovigilance (PV) Outsourcing Market Size by Type
  3. 9.2.1 China Pharmacovigilance (PV) Outsourcing Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmacovigilance (PV) Outsourcing Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmacovigilance (PV) Outsourcing Market Share by Type (2021-2032)
  6. 9.3 China Pharmacovigilance (PV) Outsourcing Market Size by Application
  7. 9.3.1 China Pharmacovigilance (PV) Outsourcing Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmacovigilance (PV) Outsourcing Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmacovigilance (PV) Outsourcing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmacovigilance (PV) Outsourcing Market Size (2021-2032)
  2. 10.2 Asia Pharmacovigilance (PV) Outsourcing Market Size by Type
  3. 10.2.1 Asia Pharmacovigilance (PV) Outsourcing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmacovigilance (PV) Outsourcing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmacovigilance (PV) Outsourcing Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmacovigilance (PV) Outsourcing Market Size by Application
  7. 10.3.1 Asia Pharmacovigilance (PV) Outsourcing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmacovigilance (PV) Outsourcing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmacovigilance (PV) Outsourcing Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmacovigilance (PV) Outsourcing Market Size by Country
  11. 10.4.1 Asia Pharmacovigilance (PV) Outsourcing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmacovigilance (PV) Outsourcing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst